Steven J. Roy
Algemeen Directeur bij VetDC, Inc.
Profiel
Steven J.
Roy is currently the President, Chief Executive Officer & Director at VetDC, Inc. Prior to this, he worked as the Director-Licensing & Alliance Management at Amgen, Inc. from 1994 to 2007 and as a Laboratory Supervisor at Ligand Pharmaceuticals, Inc. from 1988 to 1992.
He received his undergraduate degree from the University of California San Diego and his MBA from the University of Michigan.
Actieve functies van Steven J. Roy
| Bedrijven | Functie | Begin |
|---|---|---|
VetDC, Inc.
 VetDC, Inc. Agricultural Commodities/MillingProcess Industries VetDC, Inc. develops cancer drugs for pets. It is a cancer-focused veterinary biopharmaceutical company developing innovative, underutilized human technologies for use in companion animals. It offers VDC-1101, a novel anti-cancer pro-drug from Gilead Sciences for use in animal cancer. The company was founded by Terry J. Opgenorth in 2009 and is headquartered in Fort Collins, CO. | Algemeen Directeur | 01-01-2010 |
Eerdere bekende functies van Steven J. Roy
| Bedrijven | Functie | Einde |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | - |
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Opleiding van Steven J. Roy
| University of California San Diego | Undergraduate Degree |
| University of Michigan | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
VetDC, Inc.
VetDC, Inc. Agricultural Commodities/MillingProcess Industries VetDC, Inc. develops cancer drugs for pets. It is a cancer-focused veterinary biopharmaceutical company developing innovative, underutilized human technologies for use in companion animals. It offers VDC-1101, a novel anti-cancer pro-drug from Gilead Sciences for use in animal cancer. The company was founded by Terry J. Opgenorth in 2009 and is headquartered in Fort Collins, CO. | Process Industries |
